AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice.
Clinical trial NCT04835961 · COMPLETED
Trial details
- NCT number
- NCT04835961
- Sponsor
- Elpen Pharmaceutical Co. Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-01
- Primary completion
- 2022-07-01
- Enrollment
- 1037
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.